HeartWare vote for US move

By Dylan Bushell-Embling
Wednesday, 17 September, 2008

Medical device company HeartWare [ASX: HTW] has received federal court approval to go ahead with shareholder meetings to vote on its plans to redomicile in the US.

Meetings are planned for October 22.

HeartWare has appointed BDO Kendalls Corporate Finance (QLD) to independently assess the proposed scheme. BDO has determined that the scheme is in the best interest of all stockholders.

Quitting smoking increases life expectancy even for seniors

Although the benefits of quitting smoking diminish with age, there are still substantial gains...

Stem cell transplants treat blindness in mini pigs

Scientists have successfully transplanted retinas made from stem cells into blind mini pigs,...

Sugary drinks raise cardiovascular disease risk, but occasional sweets don't

Although higher sugar intake raises your risk of certain cardiovascular diseases, consuming sweet...

Content from other channels on our network

Why data access holds the key to better care

Closing cybersecurity loopholes — lessons from the US

Virus samples missing from Qld lab, investigation launched

Too much UPF could speed up biological ageing

Patient-specific 3D models to assist in surgery

Craft Brewing Beacon of Success: Green Beacon's winning strategy with Fishbowl software, global deals, and CUB acquisition

Stay Ahead of Food Safety Regulations with PPC's Allergen Management Labels

Refrigerant guide for heat pump selection

D'Orsogna to expand meat processing facilities in WA

Kokumi chemistry for rich-tasting sparkling wines

Advanced method to detect harbour sewage

Fighting waste by counting flies

Can we really 'electrify everything'?

'Tis the season for sustainable food at Christmas

Sustainable organic batteries for future energy storage